Intravaginal drug delivery devices for the administration of an antimicrobial agent
Patent 6951654 Issued on October 4, 2005. Estimated Expiration Date: March 27, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/430, Vaginal, urethral, uterine424/432, IUD or ring514/415, The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.)604/317, MEANS AND METHODS FOR COLLECTING BODY FLUIDS OR WASTE MATERIAL (E.G., RECEPTACLES, ETC.)514/603, Nitrogen in Q514/452, Plural ring oxygens in the hetero ring514/617, R contains benzene ring564/443, Hydroxy, bonded directly to carbon, or ether containing (H of -OH may be replaced by a substituted or unsubstituted ammonium ion or a Group IA or IIA light metal)424/449, Transdermal or percutaneous424/448, Pressure sensitive adhesive means514/398, Chalcogen or nitrogen bonded directly to the imidazole ring by nonionic bonding424/473, With porous, perforated, apertured, or sieved layer (e.g., dialyzing layer, microporous layer, etc.)424/433, Depot, pellet, matrix, or suppository549/533, Heavy metal containing catalyst utilized552/549, Oxygen bonded directly at the 12-position (e.g., cholic acids, desoxycholic acids, dehydrocholic acids, etc.)514/274Chalcogen bonded directly to pyrimidine at 2-position
An intravaginal antimicrobial drug delivery device is disclosed having an antimicrobial agent dispersed throughout a biocompatible elastomeric system. Also disclosed is a method of making the antimicrobial drug delivery device.
Other References
British National Formulary, pp. 280-281, (2000).
Merck Index, 11th Edition, pp. 6079, (1989).
Chien, Y. Et al., “Fundamentals of Rate-Controlled Drug Delivery”, 2nd Edition, Marcel Dekker, New York, pp. 43-137, (1992).
Zatuchni et al., Vaginal Contraception: Proceedings of an International Workshop on New Developments In Vaginal Contraception, pp. 201-208, (1979).
Acta dermato-venereologica: An international Journal for Skin Research, Clinical Dermatology and Sexually Transmitted Diseases, vol. 79, No. 5, pp. 414-415, (1999).
A. Tsuji et al., “Development of Antibiotic Releasing Intravaginal Drug Delivery System,” Proceedings of the International Congress of Chemotherapy, vol. 9, No. 124, 84-87 (1983).
March 27, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
